ArticleEmerging infectious diseases2014
Human granulocytic anaplasmosis, South Korea, 2013.
Article in Emerging infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
44 citing papers in PubMed.
- Emerging risk of tick-borne diseases in South Korea: Lyme disease, anaplasmosis, and babesiosis.Clinical and experimental vaccine research · 2026Review
- Molecular detection and characterization ofInternational journal for parasitology. Parasites and wildlife · 2025Article
- Seasonal Dynamics of Ticks and Tick-Borne Pathogens in Republic of Korea.Pathogens (Basel, Switzerland) · 2024Article
- Nationwide Survey of Vector-Borne Diseases in Rodents and Mites in Korea:Animals : an open access journal from MDPI · 2024Article
- Epidemiological, clinical, and laboratory characteristics of human granulocytic anaplasmosis in North India.Journal of clinical microbiology · 2024Article
- Diversity ofAnimals : an open access journal from MDPI · 2024Article
- Molecular Detection ofPathogens (Basel, Switzerland) · 2023Article
- Clinically differential diagnosis of human granulocytic anaplasmosis and severe fever with thrombocytopenia syndrome.Scientific reports · 2023Article
- Distant genetic variants of Anaplasma phagocytophilum from Ixodes ricinus attached to people.Parasites & vectors · 2023Article
- Under-diagnosis of vector-borne diseases among individuals suspected of having Scrub Typhus in South Korea.PloS one · 2023Article
- Human Granulocytic Anaplasmosis-A Systematic Review of Published Cases.Microorganisms · 2022Review
- Molecular Detection ofMicroorganisms · 2022Article
- Anaplasma phagocytophilum in Marmota himalayana.BMC genomics · 2022Article
- Parasitic and Vector-Borne Infections in HIV-Positive Patients in Slovakia-Evidence of an Unexpectedly High Occurrence ofPathogens (Basel, Switzerland) · 2021Article
- Human granulocytic anaplasmosis combined with rhabdomyolysis: a case report.BMC infectious diseases · 2021Article
- Relationship among bats, parasitic bat flies, and associated pathogens in Korea.Parasites & vectors · 2021Article
- Seroepidemiologic survey of emerging vector-borne infections in South Korean forest/field workers.PLoS neglected tropical diseases · 2021Article
- Human granulocytic anaplasmosis in a Single University Hospital in the Republic of Korea.Scientific reports · 2021Article
- Molecular Detection and Phylogeny of Tick-Borne Pathogens in Ticks Collected from Dogs in the Republic of Korea.Pathogens (Basel, Switzerland) · 2021Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report a patient with human granulocytic anaplasmosis in South Korea. The patient had fever and thrombocytopenia. Human granulocytic anaplasmosis was confirmed by seroconversion, PCR, and sequence analysis for Anaplasma phagocytophilum. Morulae were observed in the cultured HL-60 cells inoculated with blood from the patient.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.